NASDAQ, CEPH - Cephalon
Cephalon, Inc. is an international biopharmaceutical company dedicated to
the discovery, development and marketing of innovative products to treat human
diseases. We currently focus our efforts in four core therapeutic areas: central
nervous system ("CNS") disorders, pain, oncology and addiction. In addition to
conducting an active research and development program, we market seven
proprietary products in the United States and numerous products in various
countries throughout Europe. Consistent with our core therapeutic areas, we have
aligned our approximately 690-person U.S. field sales and sales management teams
by area. In Europe, we have a sales and marketing organization numbering
approximately 400 persons that supports our presence in nearly 20 European
countries, including France, the United Kingdom, Germany, Italy and Spain. ...
Read SEC Filing on NASDAQ.com »